Study to Investigate the Activity of AZD5122 When Given as a Single Dose to Healthy Male Subjects

Summary

The purpose of the study is to determine how quickly AZD5122 is absorbed into and cleared by the body when given to healthy, non smoking males at different dose levels. This is a 2 part study, in Part B a single group of subjects will be given both an oral dose and intravenous microdose of AZD5122 at a specialist unit. For part B there is no placebo treatment given.

Timeline

Start

2009-09

Primary completion

—

Completion

2009-11

Drugs

Indications

No indication recorded.